ZEVAMAB

Country: Արգենտինա

language: իսպաներեն

source: ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)

active_ingredient:

IBRITUMOMAB

MAH:

BAYER S.A.

pharmaceutical_form:

INYEC IV

composition:

IBRITUMOMAB TIUXETAN 1,6 MG/ML

units_in_package:

VIAL 1 X 2 ML(IBRITUMOMAB TIUXETAN) CON 1 X 2 ML(ACETATO DE SODIO) MAS 1X10 ML DE TAMPON Y 1 VACIO

authorization_date:

2015-09-08

PIL

-------------------------
DOCUMENT OUTLINE * Page 1 * Page 2 * Page 3 * Page 4 * Page 5 * Page 6 [/ar_hum_37732_PIL.html#1] * Page 7 [/ar_hum_37732_PIL.html#2] * Page 8 [/ar_hum_37732_PIL.html#3] * Page 9 [/ar_hum_37732_PIL.html#4] * Page 10 [/ar_hum_37732_PIL.html#5] * Page 11 [/ar_hum_37732_PIL.html#6] * Page 12 [/ar_hum_37732_PIL.html#7] * Page 13 [/ar_hum_37732_PIL.html#8] * Page 14 [/ar_hum_37732_PIL.html#9] * Page 15 [/ar_hum_37732_PIL.html#10] * Page 16 [/ar_hum_37732_PIL.html#11] * Page 17 [/ar_hum_37732_PIL.html#12] * Page 18 [/ar_hum_37732_PIL.html#13] * Page 19 [/ar_hum_37732_PIL.html#14] * Page 20 [/ar_hum_37732_PIL.html#15] * Page 21 [/ar_hum_37732_PIL.html#16] * Page 22 [/ar_hum_37732_PIL.html#17] * Page 23 [/ar_hum_37732_PIL.html#18] * Page 24 [/ar_hum_37732_PIL.html#19] * Page 25 [/ar_hum_37732_PIL.html#20] * Page 26 [/ar_hum_37732_PIL.html#21] * Page 27 [/ar_hum_37732_PIL.html#22] * Page 28 [/ar_hum_37732_PIL.html#23]